Evidence map›Paper›PMID 27581621›Full record

ArticleAdvanced healthcare materials2016

Bone Morphogenetic Protein-2 Promotes Human Mesenchymal Stem Cell Survival and Resultant Bone Formation When Entrapped in Photocrosslinked Alginate Hydrogels.

Steve S Ho, Nina L Vollmer, Motasem I Refaat, Oju Jeon, Eben Alsberg, Mark A Lee, J Kent Leach

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Evaluation of Demineralized Bone Matrix Particles Delivered by Alginate Hydrogel for a Bone Graft Substitute: An Animal Experimental Study.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Tissue engineering and regenerative medicine · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Steve S HoDepartment of Biomedical Engineering, University of California, Davis 451 Health Sciences Drive, Davis, CA, 95616, USA.
Nina L VollmerDepartment of Biomedical Engineering, University of California, Davis 451 Health Sciences Drive, Davis, CA, 95616, USA.
Motasem I RefaatDepartment of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA, 95817, USA.
Oju JeonDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Eben AlsbergDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
Mark A LeeDepartment of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, CA, 95817, USA.
J Kent LeachDepartment of Biomedical Engineering, University of California, Davis 451 Health Sciences Drive, Davis, CA, 95616, USA. jkleach@ucdavis.edu.
University of California, Davis · USCase Western Reserve University · US

Funding

TRAINING PROGRAM IN MUSCULOSKELETAL RESEARCHT32AR007505 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI TRIOLO, RONALD J · 1986 to 2023
$6.3M
Animal Models of Infectious Diseases Training ProgramT32AI060555 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MCSORLEY, STEPHEN J · 2004 to 2025
$3.3M
High-Throughput Microenvironment Regulation for ChondrogenesisR01AR066193 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALSBERG, EBEN, KHADEMHOSSEINI, ALI · 2015 to 2020
$2.1M
NIAID NIH HHS T32 AI060555NIAMS NIH HHS R01 AR066193NIAMS NIH HHS T32 AR007505
6 · The paper itself

Abstract

There is a substantial need to prolong cell persistence and enhance functionality in situ to enhance cell-based tissue repair. Bone morphogenetic protein-2 (BMP-2) is often used at high concentrations for osteogenic differentiation of mesenchymal stem cells (MSCs) but can induce apoptosis. Biomaterials facilitate the delivery of lower doses of BMP-2, reducing side effects and localizing materials at target sites. Photocrosslinked alginate hydrogels (PAHs) can deliver osteogenic materials to irregular-sized bone defects, providing improved control over material degradation compared to ionically cross-linked hydrogels. It is hypothesized that the delivery of MSCs and BMP-2 from a PAH increases cell persistence by reducing apoptosis, while promoting osteogenic differentiation and enhancing bone formation compared to MSCs in PAHs without BMP-2. BMP-2 significantly decreases apoptosis and enhances survival of photoencapsulated MSCs, while simultaneously promoting osteogenic differentiation in vitro. Bioluminescence imaging reveals increased MSC survival when implanted in BMP-2 PAHs. Bone defects treated with MSCs in BMP-2 PAHs demonstrate 100% union as early as 8 weeks and significantly higher bone volumes at 12 weeks, while defects with MSC-entrapped PAHs alone do not fully bridge. This study demonstrates that transplantation of MSCs with BMP-2 in PAHs achieves robust bone healing, providing a promising platform for bone repair.

Indexed as

AlginatesAnimalsApoptosisBiocompatible MaterialsBone and BonesBone Morphogenetic Protein 2Cell DifferentiationCells, CulturedCell SurvivalGlucuronic AcidHexuronic AcidsHumansHydrogelsMaleMesenchymal Stem CellsOsteogenesisAlginatesBiocompatible MaterialsBMP2 protein, humanBone Morphogenetic Protein 2Glucuronic AcidHexuronic AcidsHydrogelsbone morphogenetic protein-2mesenchymal stem cellosteogenesisphotocrosslinkingsurvival

Identifiers

PMID27581621
PMCPMC5176258
OpenAlexW2512683982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.